Skip to search formSkip to main contentSkip to account menu

Transaction counts and value totals - week

Known as: week 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Первый отечественный опыт применения адалимумаба при псориатическом артрите
Objective. To evaluated effect of adalimumab treatment on activity of arthritis, enthesitis, psoriasis and functional status in… 
2013
2013
of Doxorubicin-induced Cardiotoxicity Comparison of Cardiac Troponin I and T , Including the Evaluation of an Ultrasensitive Assay , as Indicators
Cardiac troponin (cTn) has been utilized to assess acute myocardial injury, but the cTn response in active/ongoing chronic injury… 
2010
2010
THE INFLUENCE OF POLARITY THERAPY , MASSAGE , PHYSICAL ACTIVITY , AND AGE ON FATIGUE IN BREAST CANCER ( BC ) PATIENTS DURING RADIATION THERAPY
Cancer and its treatments cause cancer-related fatigue (CRF). Research has shown that younger patients report a higher prevalence… 
2010
2010
Phase II multisite study to evaluate efficacy and safety of single weekly administration of bortezomib (BZ) and dexmethasone (dex) in newly diagnosed multiple myeloma (NDMM) patients (pts).
TPS307 Background: BZ is proteasome inhibitor with demonstrated efficacy in NDMM when given on twice a week (wk) schedule… 
2008
2008
Cilengitide in asymptomatic metastatic androgen independent prostate cancer (AIPC) patients (pts): A randomized phase II trial
5144 Background: Integrins αvβ3 and αvβ5 are involved in PC metastasis by regulating cell adhesion, migration, invasion, motility… 
2008
2008
Phase II study: Neo-adjuvant chemotherapy (NAC) with fudr (F), leucovorin (L), oxaliplatin (O), and docetaxel (D) (FLOD) in chemo-naïve operable esophageal adenocarcinoma (EAC)
15503 Background: A pathological complete response (pCR) to NAC, without the use of radiation therapy (RT), has not been… 
2005
2005
Phase I study (twice weekly schedule) of 17-allylamino-17 demethoxygeldanamycin (17AAG, NSC-704057) in patients with advanced refractory tumors
3050 Background: 17AAG is a benzoquinone antibiotic known to down-regulate oncoproteins by binding to heat shock protein 90…